277
Views
1
CrossRef citations to date
0
Altmetric
Bioanalytical Challenge

Severe Impact of Hemolysis on Stability of Phenolic Compounds

, , &
Pages 1491-1499 | Published online: 24 Jun 2013

References

  • Savoie N , GarofoloF, van Amsterdam Pet al. 2009 White Paper on recent issues in regulated bioanalysis from the third Calibration and Validation Group Workshop. Bioanalysis2(1), 53–68 (2010).
  • Savoie N , GarofoloF, van Amsterdam Pet al. 2010 White Paper on recent issues in regulated bioanalysis and global harmonization of bioanalytical guidance. Bioanalysis2(12), 1945–1960 (2010).
  • Garofolo F , RocciML, Dumont Iet al. 2011 White Paper on recent issues in bioanalysis and regulatory findings from audits and inspections. Bioanalysis3(18), 2081–2096 (2011).
  • DeSilva B , GarofoloF, RocciMet al. 2012 White Paper on recent issues in bioanalysis and alignment of multiple guidelines. Bioanalysis4(18), 2213–2226 (2012).
  • Lippi G , BlanckaertN, BoniniPet al. Haemolysis: an overview of the leading cause of unsuitable specimens in clinical laboratories. Clin. Chem. Lab. Med. 46(6), 764–772 (2008).
  • Hooser B , McCarthyJ, WilsonC, HarmsJ, StevensonG, EversonR. Effects of storage conditions and hemolysis on vitamin E concentrations in porcine serum and liver. J. Vet. Diagn. Invest. 12, 365–368 (2000).
  • Hughes N , BajajN, FanJ, WongE. Assessing the matrix effects on hemolyzed samples in bioanalysis. Bioanalysis1(6), 1057–1066 (2009).
  • Taillon M-P , LatourS, BergeronM, MessJ-N, FurtadoM, GarofoloF. Impact of hemolysis on matrix effect, recovery and ionization in bioanalytical LC-MS/MS methods. Presented at:The 58th American Society for Mass Spectrometry Conference. Salt Lake City, UT, USA, 23–27 May 2010.
  • Bérubé E-R . Taillon M-P, Furtado M, Garofolo F. Impact of sample hemolysis on drug stability in regulated bioanalysis. Bioanalysis3(18), 2097–2105 (2011).
  • Bérubé E-R , FurtadoM, GarofoloF. Hemolysis effect on the processed reconstituted stability of morphine in different reconstitution solutions. Presented at:59th American Society for Mass Spectrometry Conference. Denver, CO, USA, 5–9 June 2011.
  • Brown HC , McDanielDH, HäfligerO. Dissociation constants. In:Determination of Organic Structures by Physical Methods (Volume 1). Braude EA, Nachod FC (Eds). Academic Press, New York, NY, USA, 567–662 (1955).
  • Gawron O , DugganM, GreleckiCJ. Manometric determination of dissociation constants of phenols. Anal. Chem. 24(6), 969–970 (1952).
  • Yeh SY , LachJ. Stability of morphine in aqueous solution III. Kinetics of morphine degradation in aqueous solution. J. Pharm. Sci. 50, 35–42 (1961).
  • Vermeire A , RemonJP. Stability and compatibility of morphine. Int. J. Pharm. 187, 17–51 (1999).
  • Davis JA , GreeneRJ, HanSet al. Formation of raloxifene homo-dimer in CYP3A4, evidence for multi-substrate binding in a single catalytically competent P450 active site. Arch. Biochem. Biophys. 513(2), 110–118 (2011).
  • Liu X , SpolaricsZ. Methemoglobin is a potent activator of endothelial cells by stimulating IL-6 and IL-8 production and E-selectin membrane expression. Am. J. Physiol. Cell Physiol. 285(5), C1036–C1046 (2003).
  • Palaniandavar M , VelusamyM, MayilmuruganR. Iron(III) complexes of certain tetradentate phenolate ligands as functional models for catechol dioxygenases. J. Chem. Sci. 118(6), 601–610 (2006).
  • George P , LysterRLJ, Beetlestone J. The reaction of ferrimyoglobin with phenol. J. Biol. Chem. 236(12), 3246–3251 (1961).
  • Liu ZD , HiderRC. Design of clinically useful iron(III)-selective chelators. Med. Res. Rev. 22(1), 26–64 (2002).
  • Lauffer RB , HeistandRHII, QueLJr. Dioxygenase model studies: reaction of oxygen with iron catecholates. J. Am. Chem. Soc. 103(13), 3947–3949 (1981).
  • Arai H , BertlettBS, ChockPB, StadtmanER. Effect of bicarbonate on iron-mediated oxidation of low-density lipoprotein. Proc. Natl Acad. Sci. USA102(30), 10472–10477 (2005).
  • Nagy E , JeneyV, YachieAet al. Oxidation of hemoglobin by lipid hydroperoxide associated with low-density lipoprotein (LDL) and increased cytotoxic effect by LDL oxidation in heme oxygenase-1 (HO-1) deficiency. Cell.Mol. Biol. 51(4), 377–385 (2005).
  • US FDA . Guidance for Industry: Bioanalytical Method Validation. US Department of Health and Human Services, US FDA, Center for Drug Evaluation and Research, Rockville, MD, USA (2001).
  • Tang D , ThomasE. Strategies for dealing with hemolyzed samples in regulated LC–MS/MS bioanalysis. Bioanalysis4(22), 2715–2724 (2012).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.